Edgar Lomax Co. VA Has $17.15 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Edgar Lomax Co. VA cut its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 3.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,568 shares of the healthcare conglomerate’s stock after selling 1,315 shares during the period. UnitedHealth Group accounts for 1.1% of Edgar Lomax Co. VA’s investment portfolio, making the stock its 29th largest holding. Edgar Lomax Co. VA’s holdings in UnitedHealth Group were worth $17,146,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in UNH. WealthPlan Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 774.0% in the 3rd quarter. WealthPlan Investment Management LLC now owns 673 shares of the healthcare conglomerate’s stock worth $339,000 after purchasing an additional 596 shares in the last quarter. Millington Financial Advisors LLC lifted its holdings in shares of UnitedHealth Group by 2.7% in the 3rd quarter. Millington Financial Advisors LLC now owns 3,156 shares of the healthcare conglomerate’s stock worth $1,591,000 after purchasing an additional 82 shares in the last quarter. JFS Wealth Advisors LLC raised its position in UnitedHealth Group by 18.2% in the 3rd quarter. JFS Wealth Advisors LLC now owns 474 shares of the healthcare conglomerate’s stock valued at $239,000 after buying an additional 73 shares during the last quarter. Compass Ion Advisors LLC purchased a new stake in UnitedHealth Group in the 3rd quarter valued at $310,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its position in UnitedHealth Group by 11.2% in the 3rd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 4,165 shares of the healthcare conglomerate’s stock valued at $2,100,000 after buying an additional 421 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

NYSE UNH traded up $6.32 during trading hours on Tuesday, hitting $523.55. The company had a trading volume of 2,521,901 shares, compared to its average volume of 4,216,200. The firm has a market capitalization of $481.87 billion, a price-to-earnings ratio of 31.79, a PEG ratio of 1.52 and a beta of 0.55. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a 50 day simple moving average of $486.97 and a 200 day simple moving average of $511.04. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter last year, the company posted $6.26 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.44%. UnitedHealth Group’s dividend payout ratio is 45.97%.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on UNH. Royal Bank of Canada lowered their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. Bank of America reaffirmed a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 7th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Piper Sandler raised their target price on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Finally, Wells Fargo & Company decreased their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Three investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $570.05.

Get Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.